Caring Brands (CABR) EBITDA Margin (2024 - 2025)
Caring Brands (CABR) recorded quarterly EBITDA Margin of 889672.38% in Q4 2025, down 558.7% quarter-over-quarter from 135064.19% in Q3 2025, and down 70196894.0% on a YoY basis from N/an in Q4 2024.
Caring Brands (CABR) EBITDA Margin (2024 - 2025) Analysis & Trends
Caring Brands' EBITDA Margin history runs 2 years deep, the most recent figure standing at 889672.38% for Q4 2025.
- In Q4 2025, EBITDA Margin fell 70196894.0% year-over-year to 889672.38%; the TTM figure through Dec 2025 stood at 198715.68% (changed N/A YoY), while the FY2025 annual figure was 140807.24%, changed N/A from the prior year.
- EBITDA Margin was 889672.38% for Q4 2025 at Caring Brands, down from 135064.19% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 36714.98% in Q1 2025 to a low of 889672.38% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -1.01% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 22.74% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -170.35% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -16.25% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 21.55% |
| 10 | Caring Brands | 17.34 Mn | 19.09 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -889,672.38% |
| Sep 30, 2025 | -135,064.19% |
| Mar 31, 2025 | -36,714.98% |
| Dec 31, 2024 | -187,703.44% |